Ensysce Biosciences, Inc. (ENSC) vs Kiora Pharmaceuticals, Inc. (KPRX)
- Ensysce Biosciences, Inc. ENSC 0.34 −5.56%
- Kiora Pharmaceuticals, Inc. KPRX 1.42 −5.33%
Ensysce Biosciences, Inc. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. Ensysce Biosciences, Inc. and Kiora Pharmaceuticals, Inc. are of similar size ($7.0M and $6.6M). Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against −39.3%. Kiora Pharmaceuticals, Inc. has the higher net margin (0.00% vs −280.5%) and the lower return on invested capital (−44,053.9% vs 0.00%). Across the 16 metrics below, Kiora Pharmaceuticals, Inc. leads on 12 and Ensysce Biosciences, Inc. on 4.
Valuation
Profitability
| Metric | ENSC | KPRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 85.06% | 65.16% |
| Operating margin | (281.32%) | 0.00% | 0.00% |
| Net margin | (280.49%) | 0.00% | 0.00% |
| Free cash flow margin | (196.76%) | 0.00% | 0.00% |
| Return on equity | (1,295.01%) | (56.36%) | (50.12%) |
| Return on assets | (295.92%) | (39.43%) | (45.60%) |
| Return on invested capital | 0.00% | (44,053.91%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack